構造的心疾患用デバイス（SHD）市場 – 2029年までの世界予測

Report Overview

The global Structural heart devices market is projected to reach USD 25.69 billion by 2029 from USD 16.31 billion in 2024, at a CAGR of 9.5% from 2024 to 2029.

世界の構造的心疾患用デバイス（SHD）市場は、2024年から2029年まで9.5%のCAGRで、2024年の163億1,000万米ドルから2029年までに256億9,000万米ドルに達すると予測されています。

Drivers of growth in the market for structural heart devices include mounting incidence rates of valvular and congenital heart diseases, high advancement rates of minimally invasive technologies such as TAVR and TMVR, and rising adoption rates since global populations are aging and healthcare infrastructure is being enhanced.

“By product segment Heart Valve segment to account for the largest share during the forecast period”

The most paramount segment of the structural heart devices market is heart valves primarily due to the higher prevalence of valvular diseases such as aortic stenosis and mitral regurgitation, especially in the geriatric population. These have treatment requirements at the earlier stages, with the latest breakthroughs in minimally invasive techniques being TAVR and TMVR, which have drastically altered the approach to treating these diseases. The above techniques offer reduced recovery times, fewer surgical risks, and greater access to patients classified as high-risk or inoperable when compared to traditional open-heart surgery.

Technological upgrades, for example, next-generation valves with improved durability, better sealing, and optimized delivery mechanisms form one of this segment’s most important demand drivers. Edwards Lifesciences, Medtronic, and Abbott companies are heavily investing in developing advanced transcatheter heart valves, thus further strengthening the dominancy of the segment. In addition, the growing adoption of these products in developed and emerging markets, supported by growth in reimbursement policies and demonstrated clinical success rates, further solidifies the heart valve segment as the largest and fastest-growing category in the structural heart market.

“APAC is estimated to register the highest CAGR during the forecast period.”

The Structural heart devices market is divided into Five regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific region witnessed the highest CAGR during the forecast period. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. The increasing diabetic population and increase in obesity due to sedentary lifestyles are also driving the growth of Structural heart devices in the APAC region.

The breakdown of the profile of primary participants in the Structural heart devices market:

• By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
• By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
• By Region: North America – 40%, Europe – 30%, APAC –20%, Latin America – 5%, Middle East & Africa–5%

List of Companies Profiled in the Report

• Boston Scientific Corporation (U.S)
• Edwards Lifesciences Corporation (U.S)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S
• Abbott (U.S)
• Teleflex (U.S)
• Integer Holdings Corporation (U.S)
• Lepu Medical Technology Co.Ltd.(China)
• TTK (India)
• Artivion, Inc. (U.S)
• Venus Medtech, Inc. (China)
• Cook (U.S)
• SMT (India)
• Meril Lifesciences Pvt.Ltd (India)
• W.L Gore & Associates, Inc. (U.S)
• Cordis (U.S)
• Foldax (U.S)
• Micro Interventional Devices, Incorporated (U.S)
• Cardiac Dimensions (U.S)
• HighLife Medical (France)
• Mitralign (U.S)
• Braile Biomedica (Brazil)
• JenaValve (Germany)
• Corcym (Italy)
• Xeltis (Switzerland)
• Innovheart SRL (U.S)

Research Coverage

This report studies the Structural heart devices market based on product, procedure, end users and region. It also analyses factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the market’s opportunities and challenges for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Structural heart devices market. The report forecasts the revenue of the market segments to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers (technological advancements), restraints (Cost of the system), challenges (regulatory policies), and opportunities (Increase in minimally invasive procedures) contributing to the growth of the Structural heart devices market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Structural heart devices market.
• Market Development: Comprehensive information on the lucrative emerging markets type and region.
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Structural heart devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Structural heart devices market.

Table of Contents

1               INTRODUCTION              29

1.1           STUDY OBJECTIVES       29

1.2           MARKET DEFINITION   29

1.3           STUDY SCOPE   30

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      30

1.3.2        INCLUSIONS AND EXCLUSIONS 31

1.3.3        YEARS CONSIDERED      31

1.4           CURRENCY CONSIDERED            31

1.5           STAKEHOLDERS               32

1.6           SUMMARY OF CHANGES               32

2               RESEARCH METHODOLOGY       34

2.1           RESEARCH DATA              34

2.1.1        SECONDARY DATA          34

2.1.1.1    Key data from secondary sources       36

2.1.2        PRIMARY DATA 36

2.1.2.1    Key data from primary sources           38

2.1.2.2    Key industry insights           39

2.2           MARKET SIZE ESTIMATION         40

2.2.1        SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)                 40

2.2.2        TOP-DOWN APPROACH                41

2.2.3        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      41

2.2.4        DEMAND-SIDE ANALYSIS             41

2.3           GROWTH FORECAST      42

2.4           MARKET BREAKDOWN AND DATA TRIANGULATION                 44

2.5           MARKET SHARE ANALYSIS           45

2.6           RESEARCH ASSUMPTIONS           45

2.7           RISK ASSESSMENT           45

2.8           RESEARCH LIMITATIONS             46

3               EXECUTIVE SUMMARY  47

4               PREMIUM INSIGHTS       51

4.1           STRUCTURAL HEART DEVICES MARKET OVERVIEW                 51

4.2           NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT AND COUNTRY 52

4.3           STRUCTURAL HEART DEVICES MARKET, BY COUNTRY                 53

5               MARKET OVERVIEW       54

5.1           INTRODUCTION              54

5.2           MARKET DYNAMICS       54

5.2.1        DRIVERS               55

5.2.1.1    Growing geriatric population              55

5.2.1.2    Increasing preference for minimally invasive surgeries  56

5.2.1.3    Rising awareness about structural heart diseases            56

5.2.2        RESTRAINTS      58

5.2.2.1    High cost of devices and limited reimbursement             58

5.2.3        OPPORTUNITIES              58

5.2.3.1    Emergence of tissue-engineered heart valves  58

5.2.3.2    Expanding healthcare facilities in emerging economies 59

5.2.4        CHALLENGES    60

5.2.4.1    Regulatory and approval challenges  60

5.2.4.2    Intense competition among market players     61

5.2.4.3    Lack of skilled professionals                61

5.3           INDUSTRY TRENDS         62

5.3.1        MINIMALLY INVASIVE PROCEDURES      62

5.3.2        TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN                 62

5.3.3        AI AND MACHINE LEARNING INTEGRATION      62

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES       62

5.5           PRICING ANALYSIS          63

5.5.1        AVERAGE SELLING PRICE TREND, BY REGION   64

5.5.2        AVERAGE SELLING PRICE, BY KEY PLAYER           65

5.6           VALUE CHAIN ANALYSIS               65

5.7           SUPPLY CHAIN ANALYSIS             66

5.8           ECOSYSTEM ANALYSIS  67

5.9           INVESTMENT AND FUNDING SCENARIO               70

5.10         TECHNOLOGY ANALYSIS             71

5.10.1      KEY TECHNOLOGIES     71

5.10.1.1  Transcatheter aortic valve replacement            71

5.10.1.2  Transcatheter mitral aortic valve replacement 71

5.10.2      COMPLEMENTARY TECHNOLOGIES       72

5.10.2.1  3D printing            72

5.11         PATENT ANALYSIS          72

5.12         TRADE ANALYSIS             74

5.12.1      HS CODES           74

5.12.2      EXPORT DATA  75

5.12.3      IMPORT DATA  76

5.13         KEY CONFERENCES AND EVENTS, 2024–2025        77

5.14         CASE STUDY ANALYSIS 78

5.14.1      SAPIEN 3 TRANSCATHETER HEART VALVE FOR PRECISION PLACEMENT               78

5.14.2      MITRACLIP TRANSCATHETER EDGE-TO-EDGE REPAIR TO REDUCE HOSPITALIZATION                78

5.14.3      WATCHMAN FLX DEVICE FOR LEFT ATRIAL APPENDAGE      78

5.15         REGULATORY LANDSCAPE         79

5.15.1      REGULATORY ANALYSIS               79

5.15.1.1  North America      79

5.15.1.1.1                US           79

5.15.1.1.2                Canada   79

5.15.1.2  Europe   80

5.15.1.3  Asia Pacific            80

5.15.1.3.1                Japan      80

5.15.1.3.2                China      80

5.15.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             81

5.16         PORTER’S FIVE FORCE ANALYSIS              83

5.16.1      THREAT OF NEW ENTRANTS      85

5.16.2      THREAT OF SUBSTITUTES          85

5.16.3      BARGAINING POWER OF SUPPLIERS       85

5.16.4      BARGAINING POWER OF BUYERS             85

5.16.5      INTENSITY OF COMPETITIVE RIVALRY 85

5.17         KEY STAKEHOLDERS AND BUYING CRITERIA     86

5.17.1      KEY STAKEHOLDERS     86

5.17.2      BUYING CRITERIA           87

5.18         REIMBURSEMENT ANALYSIS      87

5.19         UNMET NEEDS AND END-USER EXPECTATIONS                 89

5.19.1      UNMET NEEDS 89

5.19.2      END-USER EXPECTATIONS         89

5.20         IMPACT OF AI/GEN AI ON STRUCTURAL HEART DEVICES MARKET            90

5.20.1      INTRODUCTION              90

5.20.2      KEY COMPANIES IMPLEMENTING AI      90

5.20.3      MARKET POTENTIAL OF AI IN STRUCTURAL HEART DEVICES MARKET            90

6               STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE      91

6.1           INTRODUCTION              92

6.2           REPLACEMENT PROCEDURES   92

6.2.1        TAVR/TAVI REPLACEMENT PROCEDURES           93

6.2.1.1    Quicker recuperation and shorter hospital stays to promote growth    93

6.2.2        SAVR PROCEDURES        95

6.2.2.1    Wide adoption for treating valvular heart diseases to sustain growth    95

6.3           REPAIR PROCEDURES    96

6.3.1        CLOSURE PROCEDURES                97

6.3.1.1    Increasing prevalence of structural heart defects to boost market                 97

6.3.2        ANNULOPLASTY              99

6.3.2.1    Growing focus on safety and efficacy to drive market    99

6.3.3        VALVULOPLASTY             100

6.3.3.1    Increasing cases of aortic stenosis and valvular regurgitation to fuel market             100

6.3.4        TMVR PROCEDURES      102

6.3.4.1    Growing preference over valve replacement to promote growth                 102

6.3.5        TEER PROCEDURES        104

6.3.5.1    Global prevalence of mitral regurgitation to expedite growth                 104

7               STRUCTURAL HEART DEVICES MARKET, BY PRODUCT                 105

7.1           INTRODUCTION              106

7.2           HEART VALVE DEVICES                107

7.2.1        TRANSCATHETER HEART VALVES           108

7.2.1.1    Transcatheter mitral valve replacement            110

7.2.1.1.1 Growing use in treating age-related degeneration and heart diseases to boost market      110

7.2.1.2    Transcatheter aortic valve replacement            112

7.2.1.2.1 Increasing instances of aortic valve replacement to aid growth                 112

7.2.2        SURGICAL VALVES          114

7.2.2.1    Mechanical valves 115

7.2.2.1.1 Higher durability and affordability to encourage growth                 115

7.2.2.2    Biological valves   116

7.2.2.2.1 Need for reduced incidence of bleeding to accelerate growth                 116

7.3           OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS              118

7.4           ANNULOPLASTY RINGS                 119

7.4.1        HIGH PREVALENCE OF MITRAL AND TRICUSPID VALVE REGURGITATION DISEASES TO PROMOTE GROWTH      119

7.5           ACCESSORIES    121

7.5.1        CATHETERS       122

7.5.1.1    Growing preference for minimally invasive procedures to fuel market    122

7.5.2        GUIDEWIRES     124

7.5.2.1    Need for precise navigation and placement of medical devices to augment growth    124

7.5.3        SHEATHS             125

7.5.3.1    Need for minimizing vascular trauma to promote growth                 125

7.5.4        OTHER ACCESSORIES    127

8               STRUCTURAL HEART DEVICES MARKET, BY END USER                 128

8.1           INTRODUCTION              129

8.1.1        HOSPITALS         129

8.1.1.1    Ability to handle large volume of patients to boost market                 129

8.1.2        AMBULATORY SURGICAL CENTRES        130

8.1.2.1    Faster procedure time and lower infection rates to drive market                 130

8.1.3        OTHER END USERS         132

9               STRUCTURAL HEART DEVICES MARKET, BY REGION                 133

9.1           INTRODUCTION              134

9.2           NORTH AMERICA             134

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 135

9.2.2        US           139

9.2.2.1    Favorable reimbursement scenario to augment growth 139

9.2.3        CANADA               143

9.2.3.1    Rising prevalence of target diseases to drive market       143

9.3           EUROPE               147

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      147

9.3.2        GERMANY           151

9.3.2.1    Increase in geriatric and obese population to stimulate growth                 151

9.3.3        UK          155

9.3.3.1    Increasing incidence of peripheral vascular diseases to support growth    155

9.3.4        FRANCE                159

9.3.4.1    Favorable government initiatives to drive market           159

9.3.5        ITALY    163

9.3.5.1    Increasing health expenditure and rising diabetes prevalence to boost market          163

9.3.6        SPAIN    166

9.3.6.1    Growing geriatric population to propel market                166

9.3.7        REST OF EUROPE             170

9.4           ASIA PACIFIC     175

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 175

9.4.2        JAPAN   180

9.4.2.1    Increasing healthcare expenditure to boost market         180

9.4.3        CHINA  184

9.4.3.1    Growing target patient population to drive market         184

9.4.4        INDIA    188

9.4.4.1    Increasing prevalence of diabetes to expedite growth    188

9.4.5        AUSTRALIA         191

9.4.5.1    Growing hospitalizations due to coronary artery diseases to fuel market    191

9.4.6        SOUTH KOREA  196

9.4.6.1    Increasing prevalence of hypertension to support growth                 196

9.4.7        REST OF ASIA PACIFIC   200

9.5           LATIN AMERICA                203

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 203

9.5.2        BRAZIL 207

9.5.2.1    Rising healthcare expenditure to aid growth    207

9.5.3        MEXICO                211

9.5.3.1    Increasing prevalence of cardiovascular diseases to spur growth                 211

9.5.4        REST OF LATIN AMERICA             215

9.6           MIDDLE EAST & AFRICA                218

9.6.1        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 218

9.6.2        GCC COUNTRIES              222

9.6.2.1    Rising cases of hypertension and associated cardiovascular diseases to drive market      222

9.6.3        REST OF MIDDLE EAST & AFRICA             225

10            COMPETITIVE LANDSCAPE         229

10.1         INTRODUCTION              229

10.2         KEY PLAYER STRATEGY/RIGHT TO WIN                229

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS                 229

10.3         REVENUE ANALYSIS, 2019–2023  230

10.4         MARKET SHARE ANALYSIS, 2023                 231

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 232

10.5.1      STARS   232

10.5.2      EMERGING LEADERS     232

10.5.3      PERVASIVE PLAYERS      233

10.5.4      PARTICIPANTS 233

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         234

10.5.5.1  Company footprint               234

10.5.5.2  Product footprint  235

10.5.5.3  Procedure footprint              236

10.5.5.4  End-user footprint                237

10.5.5.5  Region footprint   238

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        239

10.6.1      PROGRESSIVE COMPANIES         239

10.6.2      DYNAMIC COMPANIES  239

10.6.3      RESPONSIVE COMPANIES            239

10.6.4      STARTING BLOCKS         239

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 241

10.7         BRAND/PRODUCT COMPARISON             242

10.8         COMPANY VALUATION AND FINANCIAL METRICS                 242

10.8.1      FINANCIAL METRICS      242

10.8.2      COMPANY VALUATION 243

10.9         COMPETITIVE SCENARIO             243

10.9.1      PRODUCT LAUNCHES AND APPROVALS               243

10.9.2      DEALS  245

11            COMPANY PROFILES      246

11.1         KEY PLAYERS     246

11.1.1      EDWARDS LIFESCIENCES CORPORATION             246

11.1.1.1  Business overview 246

11.1.1.2  Products offered   247

11.1.1.3  Recent developments           248

11.1.1.3.1                Deals      248

11.1.1.4  MnM view              249

11.1.1.4.1                Right to win           249

11.1.1.4.2                Strategic choices   249

11.1.1.4.3                Weaknesses and competitive threats 249

11.1.2      MEDTRONIC      250

11.1.2.1  Business overview 250

11.1.2.2  Products offered   252

11.1.2.3  Recent developments           252

11.1.2.3.1                Product launches and approvals         252

11.1.2.3.2                Deals      253

11.1.2.4  MnM view              253

11.1.2.4.1                Right to win           253

11.1.2.4.2                Strategic choices   253

11.1.2.4.3                Weaknesses and competitive threats 253

11.1.3      ABBOTT               254

11.1.3.1  Business overview 254

11.1.3.2  Products offered   255

11.1.3.3  Recent developments           256

11.1.3.3.1                Product launches and approvals         256

11.1.3.3.2                Deals      257

11.1.3.4  MnM view              257

11.1.3.4.1                Right to win           257

11.1.3.4.2                Strategic choices   257

11.1.3.4.3                Weaknesses and competitive threats 257

11.1.4      BOSTON SCIENTIFIC CORPORATION     258

11.1.4.1  Business overview 258

11.1.4.2  Products offered   259

11.1.4.3  Recent developments           260

11.1.4.3.1                Product launches and approvals         260

11.1.5      TELEFLEX            261

11.1.5.1  Business overview 261

11.1.5.2  Products offered   262

11.1.5.3  Recent developments           263

11.1.5.3.1                Product launches and approvals         263

11.1.5.3.2                Deals      263

11.1.6      INTEGER HOLDINGS CORPORATION     264

11.1.6.1  Business overview 264

11.1.6.2  Products offered   265

11.1.6.3  Recent developments           266

11.1.6.3.1                Deals      266

11.1.6.3.2                Expansions             266

11.1.7      LEPU MEDICAL TECHNOLOGY CO., LTD.              267

11.1.7.1  Business overview 267

11.1.7.2  Products offered   268

11.1.7.3  Recent developments           270

11.1.7.3.1                Product launches and approvals         270

11.1.8      TTK HEALTHCARE          271

11.1.8.1  Business overview 271

11.1.8.2  Products offered   272

11.1.9      ARTIVION, INC. 273

11.1.9.1  Business overview 273

11.1.9.2  Products offered   274

11.1.10   VENUS MEDTECH (HANGZHOU) INC.    276

11.1.10.1                 Business overview 276

11.1.10.2                 Products offered   277

11.1.10.3                 Recent developments           277

11.1.10.3.1             Product launches and approvals         277

11.1.11   LIFETECH SCIENTIFIC CORPORATION  278

11.1.11.1                 Business overview 278

11.1.11.2                 Products offered   279

11.1.12   COOK    281

11.1.12.1                 Business overview 281

11.1.12.2                 Products offered   281

11.1.12.3                 Recent developments           282

11.1.12.3.1             Deals      282

11.1.13   CORDIS                 283

11.1.13.1                 Business overview 283

11.1.13.2                 Products offered   283

11.1.13.3                 Recent developments           284

11.1.13.3.1             Product launches and approvals         284

11.1.14   SMT       285

11.1.14.1                 Business overview 285

11.1.14.2                 Products offered   285

11.1.14.3                 Recent developments           286

11.1.14.3.1             Other developments             286

11.1.15   MERIL LIFE SCIENCES PVT. LTD.               287

11.1.15.1                 Business overview 287

11.1.15.2                 Products offered   288

11.1.16   W. L. GORE & ASSOCIATES, INC.                 289

11.1.16.1                 Business overview 289

11.1.16.2                 Products offered   289

11.2         OTHER PLAYERS              291

11.2.1      FOLDAX               291

11.2.2      MICRO INTERVENTIONAL DEVICES, INCORPORATED                 292

11.2.3      CARDIAC DIMENSIONS 292

11.2.4      BIOTRONIK        293

11.2.5      HIGHLIFE MEDICAL       294

11.2.6      MITRALIGN        294

11.2.7      BRAILE BIOMEDICA       295

11.2.8      JENAVALVE        295

11.2.9      CORCYM              296

11.2.10   XELTIS  296

11.2.11   INNOVHEART SRL            297

12            APPENDIX           298

12.1         DISCUSSION GUIDE        298

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                301

12.3         CUSTOMIZATION OPTIONS        303

12.4         RELATED REPORTS         303

12.5         AUTHOR DETAILS           304

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES, 2020–2023              32

TABLE 2                STRUCTURAL HEART DEVICES MARKET: RESEARCH ASSUMPTIONS           45

TABLE 3                STRUCTURAL HEART DEVICES MARKET: RISK ASSESSMENT     45

TABLE 4                GERIATRIC POPULATION, BY REGION, 2030                 56

TABLE 5                NATIONAL AVERAGE REIMBURSEMENT RATES FOR NORTH AMERICA AND EUROPE, 2024–2025 58

TABLE 6                STRUCTURAL HEART DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 68

TABLE 7                STRUCTURAL HEART DEVICES MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021–2023                 72

TABLE 8                HS CODES FOR STRUCTURAL HEART DEVICES MARKET               74

TABLE 9                EXPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023      75

TABLE 10              IMPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023      76

TABLE 11              STRUCTURAL HEART DEVICES MARKET: KEY CONFERENCES AND EVENTS,

2024–2025              77

TABLE 12              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  81

TABLE 13              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           81

TABLE 14              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 82

TABLE 15              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 82

TABLE 16              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  83

TABLE 17              STRUCTURAL HEART DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS           84

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT           86

TABLE 19              KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT               87

TABLE 20              CPT CODES FOR STRUCTURAL HEART DEVICES MARKET               88

TABLE 21              STRUCTURAL HEART DEVICES MARKET: UNMET NEEDS 89

TABLE 22              STRUCTURAL HEART DEVICES MARKET: END-USER EXPECTATIONS    89

TABLE 23              STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            92

TABLE 24              STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         92

TABLE 25              STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,

BY COUNTRY, 2022–2029 (USD MILLION)               93

TABLE 26              STRUCTURAL HEART DEVICES MARKET FOR TAVR/TAVI PROCEDURES,

BY COUNTRY, 2022–2029 (USD MILLION)               94

TABLE 27              STRUCTURAL HEART DEVICES MARKET FOR SAVR PROCEDURES,

BY COUNTRY, 2022–2029 (USD MILLION)               95

TABLE 28              STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         96

TABLE 29              STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY COUNTRY, 2022–2029 (USD MILLION)               97

TABLE 30              STRUCTURAL HEART DEVICES MARKET FOR CLOSURE PROCEDURES,

BY COUNTRY, 2022–2029 (USD MILLION)               98

TABLE 31              STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY, BY COUNTRY,

2022–2029 (USD MILLION)            100

TABLE 32              STRUCTURAL HEART DEVICES MARKET FOR VALVULOPLASTY, BY COUNTRY, 2022–2029 (USD MILLION)                 101

TABLE 33              STRUCTURAL HEART DEVICES MARKET FOR TMVR PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)                 103

TABLE 34              STRUCTURAL HEART DEVICES MARKET FOR TEER PROCEDURES, BY COUNTRY, 2022–2029 (USD MILLION)                 104

TABLE 35              STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     106

TABLE 36              STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES,

BY REGION, 2022–2029 (THOUSAND UNITS)         106

TABLE 37              STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY REGION, 2022–2029 (THOUSAND UNITS)                 107

TABLE 38              STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)            108

TABLE 39              STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES,

BY COUNTRY, 2022–2029 (USD MILLION)               109

TABLE 40              STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2022–2029 (USD MILLION)     111

TABLE 41              STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2022–2029 (USD MILLION)     113

TABLE 42              STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)                 114

TABLE 43              STRUCTURAL HEART DEVICES MARKET FOR MECHANICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)                 116

TABLE 44              STRUCTURAL HEART DEVICES MARKET FOR BIOLOGICAL VALVES, BY COUNTRY, 2022–2029 (USD MILLION)                 117

TABLE 45              STRUCTURAL HEART DEVICES MARKET FOR OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)     118

TABLE 46              STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY RINGS, BY COUNTRY, 2022–2029 (USD MILLION)            120

TABLE 47              STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,

2022–2029 (USD MILLION)            121

TABLE 48              STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY COUNTRY,

2022–2029 (USD MILLION)            122

TABLE 49              STRUCTURAL HEART DEVICES MARKET FOR CATHETERS, BY COUNTRY,

2022–2029 (USD MILLION)            123

TABLE 50              STRUCTURAL HEART DEVICES MARKET FOR GUIDEWIRES, BY COUNTRY,

2022–2029 (USD MILLION)            125

TABLE 51              STRUCTURAL HEART DEVICES MARKET FOR SHEATHS, BY COUNTRY,

2022–2029 (USD MILLION)            126

TABLE 52              STRUCTURAL HEART DEVICES MARKET FOR OTHER ACCESSORIES, BY COUNTRY, 2022–2029 (USD MILLION)                 127

TABLE 53              STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)     129

TABLE 54              STRUCTURAL HEART DEVICES MARKET FOR HOSPITALS, BY REGION,

2022–2029 (USD MILLION)            130

TABLE 55              STRUCTURAL HEART DEVICES MARKET FOR AMBULATORY SURGICAL CENTRES,

BY REGION, 2022–2029 (USD MILLION)   131

TABLE 56              STRUCTURAL HEART DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)                 132

TABLE 57              STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          134

TABLE 58              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            136

TABLE 59              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            136

TABLE 60              NORTH AMERICA: HEART VALVE DEVICES MARKET, BY TYPE,

2022–2029 (USD MILLION)            136

TABLE 61              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                137

TABLE 62              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION) 137

TABLE 63              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         138

TABLE 64              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            138

TABLE 65              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            138

TABLE 66              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)       139

TABLE 67              NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)          139

TABLE 68              US: KEY MACROECONOMIC INDICATORS                 140

TABLE 69              US: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            140

TABLE 70              US: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)                 140

TABLE 71              US: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 141

TABLE 72              US: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)                 141

TABLE 73              US: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,

2022–2029 (USD MILLION)            142

TABLE 74              US: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            142

TABLE 75              US: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         142

TABLE 76              US: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         143

TABLE 77              US: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            143

TABLE 78              CANADA: KEY MACROECONOMIC INDICATORS                 144

TABLE 79              CANADA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            144

TABLE 80              CANADA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         144

TABLE 81              CANADA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       145

TABLE 82              CANADA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         145

TABLE 83              CANADA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         145

TABLE 84              CANADA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            146

TABLE 85              CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 146

TABLE 86              CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         146

TABLE 87              CANADA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            147

TABLE 88              EUROPE: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            148

TABLE 89              EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            148

TABLE 90              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         148

TABLE 91              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       149

TABLE 92              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 149

TABLE 93              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         149

TABLE 94              EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            150

TABLE 95              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 150

TABLE 96              EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         150

TABLE 97              EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            151

TABLE 98              GERMANY: KEY MACROECONOMIC INDICATORS      151

TABLE 99              GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022– 2029 (USD MILLION)           152

TABLE 100            GERMANY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         152

TABLE 101            GERMANY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       152

TABLE 102            GERMANY: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION) 153

TABLE 103            GERMANY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         153

TABLE 104            GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            153

TABLE 105            GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 154

TABLE 106            GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         154

TABLE 107            GERMANY: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            154

TABLE 108            UK: KEY MACROECONOMIC INDICATORS                 155

TABLE 109            UK: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            156

TABLE 110            UK: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         156

TABLE 111            UK: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 156

TABLE 112            UK: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         157

TABLE 113            UK: STRUCTURAL HEART DEVICES FOR ACCESSORIES, BY TYPE,

2022–2029 (USD MILLION)            157

TABLE 114            UK: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            157

TABLE 115            UK: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         158

TABLE 116            UK: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         158

TABLE 117            UK: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            158

TABLE 118            FRANCE: KEY MACROECONOMIC INDICATORS                 159

TABLE 119            FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            160

TABLE 120            FRANCE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         160

TABLE 121            FRANCE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                160

TABLE 122            FRANCE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 161

TABLE 123            FRANCE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)                 161

TABLE 124            FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            161

TABLE 125            FRANCE: STRUCTURAL HEART DEVICES FOR REPLACEMENT PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         162

TABLE 126            FRANCE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         162

TABLE 127            FRANCE: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            162

TABLE 128            ITALY: KEY MACROECONOMIC INDICATORS                 163

TABLE 129            ITALY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            163

TABLE 130            ITALY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         164

TABLE 131            ITALY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 164

TABLE 132            ITALY: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         164

TABLE 133            ITALY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,

2022–2029 (USD MILLION)            165

TABLE 134            ITALY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            165

TABLE 135            ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            165

TABLE 136            ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         166

TABLE 137            ITALY: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            166

TABLE 138            SPAIN: KEY MACROECONOMIC INDICATORS                 167

TABLE 139            SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            167

TABLE 140            SPAIN: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         168

TABLE 141            SPAIN: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 168

TABLE 142            SPAIN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         168

TABLE 143            SPAIN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         169

TABLE 144            SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            169

TABLE 145            SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            169

TABLE 146            SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         170

TABLE 147            SPAIN: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            170

TABLE 148            REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2030 (MILLION)           171

TABLE 149            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            171

TABLE 150            REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)       172

TABLE 151            REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                172

TABLE 152            REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION) 172

TABLE 153            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         173

TABLE 154            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            173

TABLE 155            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            173

TABLE 156            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)       174

TABLE 157            REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            174

TABLE 158            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            177

TABLE 159            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            177

TABLE 160            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            177

TABLE 161            ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                178

TABLE 162            ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION) 178

TABLE 163            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         178

TABLE 164            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            179

TABLE 165            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 179

TABLE 166            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            179

TABLE 167            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            180

TABLE 168            JAPAN: KEY MACROECONOMIC INDICATORS                 181

TABLE 169            JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            181

TABLE 170            JAPAN: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            181

TABLE 171            JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       182

TABLE 172            JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         182

TABLE 173            JAPAN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         182

TABLE 174            JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            183

TABLE 175            JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            183

TABLE 176            JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         183

TABLE 177            JAPAN: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            184

TABLE 178            CHINA: KEY MACROECONOMIC INDICATORS                 184

TABLE 179          CHINA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            185

TABLE 180            CHINA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         185

TABLE 181            CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       185

TABLE 182            CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         186

TABLE 183            CHINA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         186

TABLE 184          CHINA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            186

TABLE 185            CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            187

TABLE 186            CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         187

TABLE 187          CHINA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            187

TABLE 188            INDIA: KEY MACROECONOMIC INDICATORS                 188

TABLE 189            INDIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            188

TABLE 190            INDIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            189

TABLE 191            INDIA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION) 189

TABLE 192            INDIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         189

TABLE 193            INDIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,

2022–2029 (USD MILLION)            190

TABLE 194            INDIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            190

TABLE 195            INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            190

TABLE 196            INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         191

TABLE 197            INDIA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            191

TABLE 198            AUSTRALIA: KEY MACROECONOMIC INDICATORS      192

TABLE 199            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            192

TABLE 200            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            193

TABLE 201            AUSTRALIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                193

TABLE 202            AUSTRALIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)            193

TABLE 203            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         194

TABLE 204            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            194

TABLE 205            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 194

TABLE 206            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         195

TABLE 207            AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            195

TABLE 208            SOUTH KOREA: KEY MACROECONOMIC INDICATORS      196

TABLE 209            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            197

TABLE 210            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            197

TABLE 211            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       197

TABLE 212            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         198

TABLE 213            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         198

TABLE 214            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            198

TABLE 215            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 199

TABLE 216            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            199

TABLE 217            SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            199

TABLE 218            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)                 200

TABLE 219            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)       200

TABLE 220            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                201

TABLE 221            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)            201

TABLE 222            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)            201

TABLE 223            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES, BY PROCEDURE,

2022–2029 (USD MILLION)            202

TABLE 224            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            202

TABLE 225            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)       202

TABLE 226            REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 203

TABLE 227            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            204

TABLE 228            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            204

TABLE 229            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            204

TABLE 230            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       205

TABLE 231            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)            205

TABLE 232            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         205

TABLE 233            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            206

TABLE 234            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 206

TABLE 235            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            206

TABLE 236            LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            207

TABLE 237            BRAZIL: KEY MACROECONOMIC INDICATORS                 207

TABLE 238            BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            208

TABLE 239            BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         208

TABLE 240            BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       209

TABLE 241            BRAZIL: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,

BY TYPE, 2022–2029 (USD MILLION)         209

TABLE 242            BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         209

TABLE 243            BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            210

TABLE 244            BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 210

TABLE 245            BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         210

TABLE 246            BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            211

TABLE 247            MEXICO: KEY MACROECONOMIC INDICATORS                 211

TABLE 248            MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            212

TABLE 249            MEXICO: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,

BY TYPE, 2022–2029 (USD MILLION)         212

TABLE 250            MEXICO: STRUCTURAL HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022–2029 (USD MILLION)            212

TABLE 251            MEXICO: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)            213

TABLE 252            MEXICO: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,

BY TYPE, 2022–2029 (USD MILLION)         213

TABLE 253            MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            213

TABLE 254            MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION) 214

TABLE 255            MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,

BY TYPE, 2022–2029 (USD MILLION)         214

TABLE 256            MEXICO: STRUCTURAL HEART DEVICES, MARKET, BY END USER,

2022–2029 (USD MILLION)            214

TABLE 257            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)                 215

TABLE 258            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)       215

TABLE 259            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                216

TABLE 260            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)            216

TABLE 261            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)            216

TABLE 262            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022–2029 (USD MILLION)                 217

TABLE 263            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            217

TABLE 264            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)       217

TABLE 265            REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 218

TABLE 266            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022–2029 (USD MILLION)                 219

TABLE 267            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)                 219

TABLE 268            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            219

TABLE 269            MIDDLE EAST & AFRICA: HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022–2029 (USD MILLION)            220

TABLE 270            MIDDLE EAST & AFRICA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022–2029 (USD MILLION)            220

TABLE 271            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)            220

TABLE 272            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES, BY PROCEDURE,

2022–2029 (USD MILLION)            221

TABLE 273            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            221

TABLE 274            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            221

TABLE 275            MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)                 222

TABLE 276            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            222

TABLE 277            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)       223

TABLE 278            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                223

TABLE 279            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)            223

TABLE 280            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY ACCESSORIES, 2022–2029 (USD MILLION)                 224

TABLE 281            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2022–2029 (USD MILLION)            224

TABLE 282            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            224

TABLE 283            GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)       225

TABLE 284            GCC COUNTRIES: STRUCTURAL HEART DEVICES, BY END USER,

2022–2029 (USD MILLION)            225

TABLE 285            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,

BY PRODUCT, 2022–2029 (USD MILLION)               226

TABLE 286            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022–2029 (USD MILLION)            226

TABLE 287            REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)       226

TABLE 288            REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022–2029 (USD MILLION)                227

TABLE 289            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022–2029 (USD MILLION)       227

TABLE 290            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,

BY PROCEDURE, 2022–2029 (USD MILLION)          227

TABLE 291            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)         228

TABLE 292            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022–2029 (USD MILLION)            228

TABLE 293            REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               228

TABLE 294            STRUCTURAL HEART DEVICES MARKET: DEGREE OF COMPETITION         231

TABLE 295            STRUCTURAL HEART DEVICES MARKET: PRODUCT FOOTPRINT 235

TABLE 296            STRUCTURAL HEART DEVICES MARKET: PROCEDURE FOOTPRINT            236

TABLE 297            STRUCTURAL HEART DEVICES MARKET: END-USER FOOTPRINT            237

TABLE 298            STRUCTURAL HEART DEVICES MARKET: REGION FOOTPRINT     238

TABLE 299            STRUCTURAL HEART DEVICES MARKET: KEY STARTUPS/SMES              241

TABLE 300            STRUCTURAL HEART DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024  244

TABLE 301          STRUCTURAL HEART DEVICES MARKET: DEALS, JANUARY 2021–OCTOBER 2024   245

TABLE 302            EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW   246

TABLE 303            EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED    247

TABLE 304            EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024    248

TABLE 305            MEDTRONIC: COMPANY OVERVIEW       250

TABLE 306            MEDTRONIC: PRODUCTS OFFERED        252

TABLE 307            MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–

OCTOBER 2024  252

TABLE 308            MEDTRONIC: DEALS, JANUARY 2021–OCTOBER 2024        253

TABLE 309            ABBOTT: COMPANY OVERVIEW                254

TABLE 310            ABBOTT: PRODUCTS OFFERED 255

TABLE 311            ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024         256

TABLE 312            ABBOTT: DEALS, JANUARY 2021–OCTOBER 2024                 257

TABLE 313            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   258

TABLE 314            BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED    259

TABLE 315            BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024  260

TABLE 316            TELEFLEX: COMPANY OVERVIEW            261

TABLE 317            TELEFLEX: PRODUCTS OFFERED             262

TABLE 318            TELEFLEX: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–

OCTOBER 2024  263

TABLE 319            TELEFLEX: DEALS, JANUARY 2021–OCTOBER 2024        263

TABLE 320            INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW   264

TABLE 321            INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED    265

TABLE 322            INTEGER HOLDINGS CORPORATION: DEALS, JANUARY 2021–OCTOBER 2024   266

TABLE 323            INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021–

OCTOBER 2024  266

TABLE 324            LEPU MEDICAL CO., LTD.: COMPANY OVERVIEW          267

TABLE 325            LEPU MEDICAL CO., LTD.: PRODUCTS OFFERED                 268

TABLE 326            LEPU MEDICAL CO, .LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024                 270

TABLE 327            TTK HEALTHCARE: COMPANY OVERVIEW                 271

TABLE 328            TTK HEALTHCARE: PRODUCTS OFFERED                 272

TABLE 329            ARTIVION, INC.: COMPANY OVERVIEW 273

TABLE 330            ARTIVION, INC.: PRODUCTS OFFERED  274

TABLE 331            VENUS MEDTECH (HANGZHOU) INC.: COMPANY OVERVIEW   276

TABLE 332            VENUS MEDTECH (HANGZHOU) INC.: PRODUCTS OFFERED    277

TABLE 333            VENUS MEDTECH (HANGZHOU) INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024  277

TABLE 334            LIFETECH SCIENTIFIC CORPORATION: COMPANY OVERVIEW   278

TABLE 335            LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED    279

TABLE 336            COOK: COMPANY OVERVIEW    281

TABLE 337            COOK: PRODUCTS OFFERED     281

TABLE 338            COOK: DEALS, JANUARY 2021–OCTOBER 2024                 282

TABLE 339            CORDIS: COMPANY OVERVIEW 283

TABLE 340            CORDIS: PRODUCTS OFFERED  283

TABLE 341            CORDIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–OCTOBER 2024         284

TABLE 342            SMT: COMPANY OVERVIEW        285

TABLE 343            SMT: PRODUCTS OFFERED         285

TABLE 344            SMT: OTHER DEVELOPMENTS, JANUARY 2021–OCTOBER 2024  286

TABLE 345            MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW          287

TABLE 346            MERIL LIFESCIENCES PVT. LTD.: PRODUCTS OFFERED             288

TABLE 347            W.L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW          289

TABLE 348            W.L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED             289

TABLE 349            FOLDAX: COMPANY OVERVIEW                291

TABLE 350            MICRO INTERVENTIONAL DEVICES, INCORPORATED: COMPANY OVERVIEW               292

TABLE 351            CARDIAC DIMENSIONS: COMPANY OVERVIEW                 292

TABLE 352            BIOTRONIK: COMPANY OVERVIEW         293

TABLE 353            HIGHLIFE MEDICAL: COMPANY OVERVIEW                 294

TABLE 354            MITRALIGN: COMPANY OVERVIEW         294

TABLE 355            BRAILE BIOMEDICA: COMPANY OVERVIEW                 295

TABLE 356            JENAVALVE: COMPANY OVERVIEW         295

TABLE 357            CORCYM: COMPANY OVERVIEW               296

TABLE 358            XELTIS: COMPANY OVERVIEW  296

TABLE 359            INNOVHEART SRL: COMPANY OVERVIEW                 297

LIST OF FIGURES

FIGURE 1              MARKETS COVERED AND REGIONAL SCOPE COVERED            30

FIGURE 2              STRUCTURAL HEART DEVICES MARKET: RESEARCH DESIGN         34

FIGURE 3              PRIMARY SOURCES         37

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION     39

FIGURE 5              MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS            40

FIGURE 6              STRUCTURAL HEART DEVICES MARKET: TOP-DOWN APPROACH          41

FIGURE 7              MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT     42

FIGURE 8              STRUCTURAL HEART DEVICES MARKET: CAGR PROJECTIONS, 2024–2029               43

FIGURE 9              DATA TRIANGULATION                44

FIGURE 10            STRUCTURAL HEART DEVICES, BY PRODUCT, 2024 VS. 2029 (USD MILLION)      47

FIGURE 11            STRUCTURAL HEART DEVICES MARKET FOR HEART VALVES, BY TYPE,

2024 VS. 2029 (USD MILLION)      48

FIGURE 12            STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,

2024 VS. 2029 (USD MILLION)      48

FIGURE 13            STRUCTURAL HEART DEVICES MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)      49

FIGURE 14            GEOGRAPHIC SNAPSHOT OF GLOBAL STRUCTURAL HEART DEVICES MARKET               50

FIGURE 15            INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET             51

FIGURE 16            US AND HEART VALVE DEVICES LED NORTH AMERICAN MARKET IN 2023        52

FIGURE 17            CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       53

FIGURE 18            STRUCTURAL HEART DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 54

FIGURE 19            INDUSTRY TRENDS IN STRUCTURAL HEART DEVICES MARKET            62

FIGURE 20            STRUCTURAL HEART DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES                 63

FIGURE 21            AVERAGE SELLING PRICE TREND OF TRANSCATHETER HEART VALVES, BY REGION, 2021–2023 (USD)                 64

FIGURE 22            AVERAGE SELLING PRICE TREND OF SURGICAL HEART VALVES, BY REGION,

2021–2023 (USD MILLION)            64

FIGURE 23            AVERAGE SELLING PRICE OF BIOLOGICAL VALVES, BY KEY PLAYER (2023)  65

FIGURE 24            STRUCTURAL HEART DEVICES MARKET: VALUE CHAIN ANALYSIS              66

FIGURE 25            STRUCTURAL HEART DEVICES MARKET: SUPPLY CHAIN ANALYSIS             67

FIGURE 26            STRUCTURAL HEART DEVICES MARKET: ECOSYSTEM ANALYSIS  69

FIGURE 27            STRUCTURAL HEART DEVICES MARKET: INVESTMENT AND FUNDING SCENARIO, 2018–2023          70

FIGURE 28            STRUCTURAL HEART DEVICES MARKET: PATENT ANALYSIS,

JANUARY 2014–NOVEMBER 2024                 73

FIGURE 29            STRUCTURAL HEART DEVICES MARKET: PORTER’S FIVE FORCE ANALYSIS              84

FIGURE 30            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL

HEART DEVICES, BY PRODUCT 86

FIGURE 31            KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT               87

FIGURE 32            NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET SNAPSHOT    135

FIGURE 33            ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET SNAPSHOT       176

FIGURE 34            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET      229

FIGURE 35            REVENUE ANALYSIS FOR KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET, 2019–2023          230

FIGURE 36            MARKET SHARE ANALYSIS OF KEY PLAYERS IN STRUCTURAL HEART DEVICES MARKET (2023)  231

FIGURE 37            STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       233

FIGURE 38            STRUCTURAL HEART DEVICES MARKET: COMPANY FOOTPRINT 234

FIGURE 39            STRUCTURAL HEART DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 240

FIGURE 40            STRUCTURAL HEART DEVICES MARKET: BRAND/PRODUCT COMPARISON             242

FIGURE 41            EV/EBITDA OF KEY VENDORS   242

FIGURE 42            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      243

FIGURE 43            EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)      247

FIGURE 44            MEDTRONIC: COMPANY SNAPSHOT (2023)                 251

FIGURE 45            ABBOTT: COMPANY SNAPSHOT (2023)  255

FIGURE 46            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)      259

FIGURE 47            TELEFLEX: COMPANY SNAPSHOT (2023)                 262

FIGURE 48            INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)      265

FIGURE 49            LEPU MEDICAL CO., LTD.: COMPANY SNAPSHOT (2023)             268

FIGURE 50            TTK HEALTHCARE: COMPANY SNAPSHOT (2023)    272

FIGURE 51            ARTIVION, INC.: COMPANY SNAPSHOT (2023)                 274

FIGURE 52            VENUS MEDTECH (HANGZHOU) INC.: COMPANY SNAPSHOT (2023)      276

FIGURE 53            LIFETECH SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)      279

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧